Hira Mian: Real-World Outcomes of 1,477 TIE Patients in Canada
Hira Mian, Hematology Oncologist, Multiple Myeloma Lead at Hamilton Health Sciences, shared a post on X about a paper published in American Journal of Hematology:
“Outcomes of 1477 TIE patients treatment in Canada (n=742 Rd, n=392 VRd, n=343 DRd). DRd outperforms for both TTNT and OS. Hopefully quads getting funded soon. thank you team with Raj Chakraborty, Nadine A, Luciano J Costa, Alissa V, Rafael Fonseca, Shaji Kumar.”
Title: Real-World Outcomes of Transplant Ineligible Older Adults With Multiple Myeloma Treated With Novel Regimens: A Population-Based Retrospective Cohort Study
Authors: Nadine Abdallah, Hira Mian, Hsien Seow, Gregory P. Pond, Anastasia Gayowsky, Alissa Visram, Luciano J. Costa, Tanya M. Wildes, Rafael Fonseca, Charlotte Pawlyn, Gordon Cook, Shaji Kumar, Rajshekhar Chakraborty
Read the full article.
More posts featuring Hira Mian on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023